Bluebird Bio

bluebirdbio.com

bluebird bio is a clinical-stage biotechnology company focused on developing innovative gene therapies for severe genetic diseases, including beta-thalassemia, cerebral adrenoleukodystrophy, and sickle cell disease. With over a decade of experience, the company has established itself as a leader in the gene therapy field, leveraging its proprietary lentiviral vector technology to provide one-time treatments that aim to correct genetic defects at their source. bluebird bio has successfully treated more than 170 patients across 8 clinical trials, showcasing its commitment to advancing patient care and improving outcomes. The company collaborates with various partners and organizations to enhance its research and development efforts, positioning itself strongly in the biotechnology market.